Hepatitis B virus reactivation in adjuvant chemotherapy for breast cancer

Breast Cancer

Volumn 20, Issue 4, 2013, Pages 367-370

  Ide, Yoshimi ^a   Ito, Yoshinori ^a   Takahashi, Shunji ^a   Tokudome, Nahomi ^a   Kobayashi, Kokoro ^a   Sugihara, Tsutomu ^a   Hattori, Masaya ^a   Yokoyama, Masahiro ^a   Uchiyama, Akira ^b   Inoue, Kazuaki ^c   Sakurai, Norio ^d   Hatake, Kiyohiko ^a  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^d Tokyo Rinkai Hospital   (Japan)

Author keywords

Breast cancer; Chemotherapy; HBV reactivation

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ENTECAVIR; ESTROGEN RECEPTOR; FLUOROURACIL; GLYCYRRHIZIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; INTERFERON; PREDNISOLONE; PROGESTERONE RECEPTOR; URSODEOXYCHOLIC ACID;

ADJUVANT THERAPY; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER SURGERY; CARCINOMA; CASE REPORT; CAUSE OF DEATH; CONSERVATIVE TREATMENT; DEATH; FATIGUE; FEMALE; FEVER; HEPATITIS B; HEPATITIS B VIRUS; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE; LEUKOCYTE COUNT; LIVER DYSFUNCTION; LIVER FAILURE; LOSS OF APPETITE; MULTIPLE CYCLE TREATMENT; PARTIAL MASTECTOMY; PLASMAPHERESIS; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TOXIC HEPATITIS; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VERTIGO; VIRUS REACTIVATION;

ADENOCARCINOMA, SCIRRHOUS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIVIRAL AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FATAL OUTCOME; FEMALE; FLUOROURACIL; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; VIRUS ACTIVATION;

EID: 84892830492     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/s12282-010-0213-x     Document Type: Article

References (11)

1. Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol. 2007;136(5):699-712.
2. Simpson ND, Simpson PD, Ahmed AM, Nguyen MH, Garcia G, Ahmed A, et al. Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine. J Clin Gastroenterol. 2003;37(1):68-71.
3. Lubel JS, Testro AG, Angus PW. Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management. Intern Med J. 2007;37(10):705-12.
4. Dai MS, Wu PF, Shyu RY, Lu JJ, Chao TY. Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration. Liver Int. 2004;24(6):540-6.
5. Dai MS, Chao TY. Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: prophylactic or preemptive? Breast Cancer Res Treat. 2005;92(1):95-6.
6. Yeo W, Ho WH, Hui P, Chan PKS, Lam KC, Johnson PJ, et al. Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients. Breast Cancer Res Treat. 2004;88(3):209-15.
7. Horii R, Akiyama F, Ito Y, Iwase T. Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer. Br J Cancer. 2007;97(5):654-8.
8. Idilman R, Arat M, Soydan E, Touruner M, Soykan I, Akan H, et al. Lamivudine prophylaxis for prevention of chemotherapyinduced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies. J Viral Hepat. 2004;11(2):141-7.
9. Tsubouchi H, Kumada H, Kiyosawa K, Mochida S, Sakaida I, Kumagai K, et al. Prevention of immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection-joint report of the Intractable Liver Disease Study Group of Japan and the Japanese Study Group of the Standard Antiviral Therapy for Viral Hepatitis. Kanzo. 2009;50:38-42.
10. Morgan M, Park W, Keeffe EB. Diagnosis and treatment of chronic hepatitis B: an update. Minerva Gastroenterol Dietol. 2007;53(1):25-41.
11. Loomba R, Rowley A, Wesly R, Liang TJ, Hoofnagle JH, Csako G. Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Ann Intern Med. 2008; 148(7):519-28.